Grey Wolf Therapeutics Logo Grey Wolf Therapeutics Logo
    • Science
      • Our Approach
      • Pipeline
    • About
    • Our Team
      • Team
      • The Board
      • Advisors
    • Investors
    • News
    • Contact Us

TEAM

Tom McCarthy

Tom McCarthy

Executive Chairman, Co-founder

Peter Joyce

Peter Joyce

Chief Executive Officer, Co-founder

Martin Quibell

Martin Quibell

Director of Medicinal Chemistry

Kirsty McCarthy

Kirsty McCarthy

Chief Operating Officer

THE BOARD

Tom McCarthy

Tom McCarthy

Executive Chairman, Co-founder

Peter Joyce

Peter Joyce

Chief Executive Officer, Co-founder

Stuart-Onions

Stuart Onions

Board Observer

Raphaël Wisniewski

Raphael Wisniewski

Board Member - Partner at Andera Partners (BioDiscovery)

Brent Ahrens

Brent Ahrens

Board Member - General Partner at Canaan (West Coast)

Thierry-Hercend

Thierry Hercend

Board Member

ADVISORS

Stuart Hughes

Chief Executive Officer, Pathios Therapeutics

Anil Singhal

Anil Singhal

Board Member, TriSalus Life Sciences

Edd James

Associate Professor of Cancer Immunology, University of Southampton

John Pollard

John Pollard

VP, Global Head of Translational Medicine Oncology, Bayer Pharmaceuticals

John Castle

John Castle

Chief Data Scientist, Monte Rosa Therapeutics

Julian

Julian Golec

Independent Consultant

Eliot Forster

Chief Executive Officer, F-star

Michael Koslowski

Michael Koslowski

CMO, Gamma Delta

Paul Leeson

Paul Leeson

Independent Consultant

Nicola Ternette

Associate Professor, Antigen Discovery, University of Oxford

Grey Wolf Therapeutics Logo
  • Copyright © 2021 by Grey Wolf Therapeutics. All rights reserved.
  • Privacy Policy

Cookies

This site uses cookies to improve site performance and offer advertising tailored to your interests. Find out more.